Ki 16425
SIGMA/SML0971 - ≥98% (HPLC)
Synonym: 3-
CAS Number: 355025-24-0
Empirical Formula (Hill Notation): C23H23ClN2O5S
Molecular Weight: 474.96
Linear Formula: C23H23ClN2O5S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C23H23ClN2O5S/c1-14-21 |
| InChI key | LLIFMNUXGDHTRO-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | S(CCC(=O)O)Cc1ccc(cc1)c2[ |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | −20°C |
| Application: | Ki 16425 has been used as a chemical inhibitor to study the regulation of LPA (lysophosphatidic acid) on LPAR(LPA receptor) subtypes. |
| Biochem/physiol Actions: | Ki 16425 possesses a short-lived inhibitory activity. It has been studied that Ki 16425 is effective in the inhibition of neuropathic pain‐like behaviors. |
| Biochem/physiol Actions: | Ki16452 is a potent antagonist of the lysophosphatidic acid receptors LPA1 and LPA3, with greater than 30-fold selectivity for LPA1 over LPA2. The Ki values for LPA1 and LPA3 are 250 nM and 360 nM, respectively. |
| Biochem/physiol Actions: | Ki16452 is a potent antagonist of the lysophosphatidic acid receptors LPA1 and LPA3. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

